Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma

Abstract

These encouraging data provide a rationale for molecularly matched targeted therapy in glioma patients. For further validation, future study designs need to additionally consider the prevalence and persistence of actionable molecular alterations in patient tissue.